Defined human cellular systems in the study of glioma development - PubMed (original) (raw)
Review
Defined human cellular systems in the study of glioma development
Russell O Pieper. Front Biosci. 2003.
Abstract
The creation and characterization of permanent cell lines derived from primary human gliomas in the 1960s gave scientists access to unlimited, renewable material in which to study the development of brain tumors. These cells, however, were already tumorigenic and selected for growth in culture, limiting the amount of information that could be gathered about the events that led to the formation of their tumors of origin. In response to these limitations, investigators moved to the study of primary tumors to identify in a correlative fashion the lesions important in tumor formation, and to the use of animal models to gain information about the transformation process. While these approaches have been unarguably successful, they too are limited by their correlative nature (in the case of cytogenetic studies) and their potential lack of direct relevance to human cancer (in the case of mouse models). Recent developments in the isolation and manipulation of human cells have allowed investigators a fresh chance to address questions about brain tumors in a direct fashion. The present review serves as a summary of important recent findings derived from the use of defined human cells in the study of gliomas.
Similar articles
- Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ, Dios RR, Hattab EM, Burrell K, Rakopoulos P, Sabha N, Hawkins C, Zadeh G, Rutka JT, Cohen-Gadol AA. Diaz RJ, et al. J Neurosurg. 2015 Jun;122(6):1360-9. doi: 10.3171/2015.2.JNS132507. Epub 2015 Apr 3. J Neurosurg. 2015. PMID: 25839919 - A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC. Holland EC. Toxicol Pathol. 2000 Jan-Feb;28(1):171-7. doi: 10.1177/019262330002800122. Toxicol Pathol. 2000. PMID: 10669005 - TWIST is expressed in human gliomas and promotes invasion.
Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA, Rostomily RC. Elias MC, et al. Neoplasia. 2005 Sep;7(9):824-37. doi: 10.1593/neo.04352. Neoplasia. 2005. PMID: 16229805 Free PMC article. - The Updated World Health Organization Glioma Classification: Cellular and Molecular Origins of Adult Infiltrating Gliomas.
Pisapia DJ. Pisapia DJ. Arch Pathol Lab Med. 2017 Dec;141(12):1633-1645. doi: 10.5858/arpa.2016-0493-RA. Arch Pathol Lab Med. 2017. PMID: 29189064 Review. - Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B, Reifenberger G. Malzkorn B, et al. Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Pathologe. 2019. PMID: 31025086 Review. English.
Cited by
- Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation.
Bakshi HA, Faruck HL, Ravesh Z, Ansari P, Hannan JMA, Hashimoto R, Takayama K, Farzand R, Nasef MM, Mensah A, Aljabali AAA, Mishra V, Charbe NB, Goyal R, Negi P, Serrano-Aroca Á, Bahar B, El-Tanani M, Courtenay AJ, McCarron P, Jack IG, Tambuwala MM. Bakshi HA, et al. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221096766. doi: 10.1177/15347354221096766. Integr Cancer Ther. 2022. PMID: 35796303 Free PMC article. Review. - Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.
Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A. Ertel A, et al. Mol Cancer. 2006 Nov 2;5(1):55. doi: 10.1186/1476-4598-5-55. Mol Cancer. 2006. PMID: 17081305 Free PMC article. - IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, Viale A, Morris LG, Huse JT, Mellinghoff IK, Chan TA. Turcan S, et al. Nature. 2012 Feb 15;483(7390):479-83. doi: 10.1038/nature10866. Nature. 2012. PMID: 22343889 Free PMC article. - Harnessing preclinical mouse models to inform human clinical cancer trials.
Gutmann DH, Hunter-Schaedle K, Shannon KM. Gutmann DH, et al. J Clin Invest. 2006 Apr;116(4):847-52. doi: 10.1172/JCI28271. J Clin Invest. 2006. PMID: 16585951 Free PMC article. Review.